Roche Gets CE-IVD Mark for MRSA Test | GenomeWeb

NEW YORK (GenomeWeb News) – Roche has received the CE-IVD Mark in Europe for its LightCycler test for methicillin-resistant Staphylococcus aureus allowing it to be sold for clinical use in the EU, the firm said today.

The assay provides direct detection of nasal colonization with MRSA and runs on Roche's LightCycler 2.0 instrument using PCR.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.

Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.

A startup company is offering a test to analyze soil samples from farms for pathogens.

Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.